Newsweek

Freedom From Choice: How Big Data Manipulates Voters

Political operatives used fake news, Big Data and Facebook to suppress the vote and rile up racists in 2016. It's going to be even uglier next time around.
2017_06_16_Cover_2110 × 1419

The opening chords of Creedence Clearwater Revival’s “Bad Moon Rising” rocked a hotel ballroom in New York City as a nattily dressed British man strode onstage several weeks before last fall’s U.S. election.

I see the bad moon rising,

I see trouble on the way

The speaker, Alexander Nix, an Eton man, was very much among his own kind—global elites with names like Buffett, Soros, Brokaw, Pickens, Petraeus and Blair. Trouble was indeed on the way for some of the attendees at the annual summit of policymakers and philanthropists whose world order was about to be wrecked by the American election. But for Nix, chief executive officer of a company working for the Trump campaign, that mayhem was a very good thing.

He didn’t mention it that day, but his company, Cambridge Analytica, had been selling its services to the Trump campaign, which was building a massive database of information on Americans. The company’s capabilities included, among other things, “psychographic profiling” of the electorate. And while Trump’s win was in no way assured on that afternoon, Nix was there to give a cocky sales pitch for his cool new product.

“It’s my privilege to speak to you today about the power of Big Data and psychographics in the electoral process,” he began. As he clicked through slides, he explained how Cambridge Analytica can appeal directly to people’s emotions, bypassing cognitive roadblocks, thanks to the oceans of data it can access on every man and woman in the country.

After describing Big Data, Nix talked about how Cambridge was mining it for political purposes, to identify “mean personality” and then segment personality types into yet more specific subgroups, using other variables, to create ever smaller groups susceptible to precisely targeted messages.

To illustrate, he walked the audience through what he called “a real-life example” taken from the company’s data on the American electorate, starting with a large anonymous group with a general set of personality types and moving down to the most specific—one man, it turned out, who was easily identifiable.

Nix started with a group of 45,000 likely Republican Iowa caucusgoers who needed a little push—what he calls a “persuasion message”—to get out and vote for Ted Cruz (who used Cambridge Analytica early in the 2016 primaries). That group’s specifics had been fished out of the data stream by an algorithm sifting the thousands of digital data points of their lives. Nix was focusing on a personality subset the company’s algorithms determined to be “very low in neuroticism, quite low in openness and slightly conscientious.”

Click. A screen of graphs and pie charts.

“But we can segment further. We can look at what issue they care about. Gun rights I’ve selected. That narrows the field slightly more.”

Click. Another screen of graphs and pie charts, but with some circled specifics.

“And now we know we need a message on gun rights. It needs to be a persuasion message, and it needs to be nuanced according to the certain personality type we are interested in.”

Click. Another screen, the state of Iowa dotted with tiny reds and blues—individual voters.

“If we wanted to drill down further, we could resolve

You’re reading a preview, subscribe to read more.

More from Newsweek

Newsweek12 min read
The Inconceivable Search For Sperm
SINGLE WOMEN AND LGBTQ+ COUPLES are increasingly pursuing pregnancy via known donors—people they find on the internet, in Facebook groups and through dating-like apps. In her own quest to become a solo mother by choice, investigative journalist Valer
Newsweek3 min read
Newsweek US
GLOBAL EDITOR IN CHIEF _ Nancy Cooper VICE PRESIDENT, DIGITAL _ Laura Davis DIRECTOR OF OPERATIONS _ Melissa Jewsbury OPINION EDITOR _ Batya Ungar-Sargon GLOBAL PUBLISHING EDITOR _ Chris Roberts SENIOR EDITOR-AT-LARGE _ Josh Hammer EDITORIAL Managi
Newsweek5 min read
‘Deadly Risk’ of Fat-Loss Drugs
“MIRACLE” FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned. The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2

Related Books & Audiobooks